Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH

23.15

+0.11(+0.48%)

Updated at September 30 10:40AM

Currency In CNY

Valuation

Market Cap8.8B
Enterprise Value9.06B
P/E Ratio-294.43
PEG Ratio6.55
Price/Sales Ratio6.87
Price/Book Ratio2.38
Enterprise/Revenue7.04
Enterprise/EBITDA920.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.02
Operating Margin-0.05

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue1.38B
Revenue/Share3.36
Gross Profit963.54M
EBITDA-17.4M
Net Income-18.09M
Diluted EPS-0.05

Balance Sheet

Total Cash2.91B
Total Cash/Share7.32
Total Debt1.07B
Total Debt/Equity0.28
Current Ratio3.21
Book Value Per Share9.67

Price History

52-Week Change-5.26
52-Week High29.69
52-Week Low19.28
Moving Average 50 Days24.28
Moving Average 200 Days22.86

Statistics

Average Volume3.13M
Shares Outstanding397.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield0.78
Payout Ratio-4.36
Last Split FactorN/A
Last Split DateN/A